|Bloomage BioTechnology Corporation Limited -- Hong Kong Stock|| |
HKD 16.24 0.24 1.5%
Mr. Yau Waiyan is NonExecutive Director of Bloomage BioTechnology Corporationrationration Limited. Mr. Yau is an associate member of the Hong Kong Institute of Certified Public Accountants
Age: 39 Executive Since 2016
86 10 8567 0099 http://www.bloomagebio-tech.com
Yau graduated from the Hong Kong University of Science and Technology with a bachelor degree in professional accounting. Prior to joining the Company, Mr. Yau has worked for an international accounting firm for over 10 years.
The company has return on total asset (ROA)
of 7.25 %
which means that it generated profit of $7.25 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE)
of 13.14 %
meaning that it generated $13.14 on every $100 dollars invested by stockholders.
The company has accumulated 99.22 M in total debt with debt to equity ratio (D/E) of 39.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Bloomage BioTechnology Corporation Limited has Current Ratio of 7.27 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Bloomage BioTechnology Corporationration Limited, an investment holding company, develops, manufactures, and sells biochemical solutions in the People?s Republic of China, Asia, the Americas, and internationally. Bloomage BioTechnology Corporation Limited (0963) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Jinan, and employs 758 people.